Health Care Company Zevra Therapeutics Announces Merger With Acer Therapeutics
Portfolio Pulse from Benzinga Insights
Zevra Therapeutics (NASDAQ:ZVRA) has announced a merger with Acer Therapeutics (NASDAQ:ACER), expected to be completed in Q4 of 2023. Zevra will give Acer $15 million in ZVRA stock in exchange for ACER stock.
August 31, 2023 | 3:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acer Therapeutics is merging with Zevra Therapeutics, receiving $15 million in ZVRA stock in exchange for ACER stock.
The merger with Zevra Therapeutics could potentially increase Acer's market share and diversify its portfolio, which could positively impact its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Zevra Therapeutics is merging with Acer Therapeutics, giving $15 million in ZVRA stock for ACER stock.
The merger with Acer Therapeutics could potentially increase Zevra's market share and diversify its portfolio, which could positively impact its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100